HomeINRLF • OTCMKTS
add
Valneva SE
Nakaraang pagsara
$1.98
Sakop ng taon
$1.98 - $5.40
Market cap
295.94M EUR
Average na Volume
794.00
P/E ratio
-
Dividend yield
-
Primary exchange
EPA
Mga balita tungkol sa merkado
Mga Financial
Income Statement
Kita
Net na kita
| (EUR) | Set 2024info | Y/Y na pagbabago |
|---|---|---|
Kita | 45.82M | 20.36% |
Gastos sa pagpapatakbo | 13.66M | 234.94% |
Net na kita | -9.24M | 73.01% |
Net profit margin | -20.16 | 77.58% |
Kita sa bawat share | -0.15 | 71.80% |
EBITDA | -12.40M | -16.52% |
Aktuwal na % ng binabayarang buwis | 28.71% | — |
Balance Sheet
Kabuuang asset
Kabuuang sagutin
| (EUR) | Set 2024info | Y/Y na pagbabago |
|---|---|---|
Cash at mga panandaliang investment | 156.34M | -8.71% |
Kabuuang asset | 516.61M | -0.75% |
Kabuuang sagutin | 299.14M | -17.59% |
Kabuuang equity | 217.47M | — |
Natitirang share | 140.53M | — |
Presyo para makapag-book | 1.28 | — |
Return on assets | -6.31% | — |
Return on capital | -7.80% | — |
Cash Flow
Net change in cash
| (EUR) | Set 2024info | Y/Y na pagbabago |
|---|---|---|
Net na kita | -9.24M | 73.01% |
Cash mula sa mga operasyon | -10.48M | 85.32% |
Cash mula sa pag-invest | -15.38M | -751.14% |
Cash mula sa financing | 51.86M | 45.62% |
Net change in cash | 24.92M | 175.16% |
Malayang cash flow | -41.46M | 41.47% |
Tungkol
Valneva SE is a French biotech company headquartered in Saint-Herblain, France, developing and commercializing vaccines for infectious diseases. It has manufacturing sites in Livingston, Scotland; Solna, Sweden, and Vienna, Austria; with other offices in France, Canada and the United States. Wikipedia
Itinatag
2013
Website
Mga Empleyado
700
